Genprex cancer gene therapy paired with AZ, Merck lung cancer drugs
An experimental gene therapy developed by Texas biotech Genprex will be paired with AstraZeneca’s Tagrisso and Merck & Co’s Keytruda – both leading their respective drug classes in the treatment of non-small cell lung cancer (NSCLC).
original article: Genprex cancer gene therapy paired with AZ, Merck lung cancer drugs | pharmaphorum